Adaptive Biotechnologies (ADPT) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Adaptive Biotechnologies (ADPT) over the last 6 years, with Q3 2025 value amounting to $0.06.
- Adaptive Biotechnologies' EPS (Weighted Average and Diluted) rose 12727.27% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.53, marking a year-over-year increase of 6044.78%. This contributed to the annual value of -$1.08 for FY2024, which is 3045.32% up from last year.
- Per Adaptive Biotechnologies' latest filing, its EPS (Weighted Average and Diluted) stood at $0.06 for Q3 2025, which was up 12727.27% from -$0.17 recorded in Q2 2025.
- In the past 5 years, Adaptive Biotechnologies' EPS (Weighted Average and Diluted) ranged from a high of $0.06 in Q3 2025 and a low of -$0.48 during Q4 2023
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.33 (2023), whereas its average is -$0.31.
- In the last 5 years, Adaptive Biotechnologies' EPS (Weighted Average and Diluted) tumbled by 7142.86% in 2023 and then skyrocketed by 12727.27% in 2025.
- Quarter analysis of 5 years shows Adaptive Biotechnologies' EPS (Weighted Average and Diluted) stood at -$0.44 in 2021, then skyrocketed by 36.36% to -$0.28 in 2022, then plummeted by 71.43% to -$0.48 in 2023, then surged by 52.25% to -$0.23 in 2024, then surged by 126.18% to $0.06 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.06 for Q3 2025, versus -$0.17 for Q2 2025 and -$0.2 for Q1 2025.